|
End-of-day quote
Egyptian Exchange
|
||
| - EGP | - |
|
| 27/09 | The Arab Drug Company Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 21/05 | The Arab Drug Company Reports Earnings Results for the Nine Months Ended March 31, 2026 | CI |
| Market Cap | 326.41Cr 6.23Cr 5.56Cr 5.19Cr 4.71Cr 8.87Cr 603.32Cr 8.96Cr 62Cr 24Cr 306.58Cr 23Cr 23Cr 985.97Cr | P/E 2025 |
6.08x | P/E 2026 | 12.4x |
|---|---|---|---|---|---|
| Enterprise Value | 370.46Cr 7.07Cr 6.31Cr 5.89Cr 5.35Cr 10Cr 684.75Cr 10Cr 71Cr 28Cr 347.95Cr 27Cr 26Cr 1.12TCr | EV / Sales 2025 |
1.47x | EV / Sales 2026 | 2.43x |
| Free-Float |
18.09% | Yield 2025 |
4.14% | Yield 2026 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Tariq Ali
DFI | Director of Finance/CFO | - | - |
Yosef Omr Amer
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | - | |
| Director/Board Member | - | - | |
| Director/Board Member | - | 30/09/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.61% | +1.72% | +38.30% | +104.56% | 1,06000Cr | |
| -0.76% | -0.84% | +35.21% | +61.78% | 62TCr | |
| +0.39% | +4.81% | +17.81% | +82.70% | 48TCr | |
| -0.29% | -0.99% | +64.79% | +36.25% | 35TCr | |
| -2.03% | +1.03% | +22.25% | +42.16% | 35TCr | |
| -1.92% | -1.87% | +11.94% | +33.20% | 27TCr | |
| -2.36% | -3.16% | -6.95% | +8.68% | 25TCr | |
| -1.37% | +0.04% | +38.29% | +50.05% | 22TCr | |
| +0.17% | -0.27% | +24.40% | +95.98% | 18TCr | |
| Average | -1.58% | -0.48% | +27.34% | +57.26% | 42.09TCr | |
| Weighted average by Cap. | -1.48% | +0.04% | +30.65% | +67.62% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 111.82Cr 2.13Cr 1.91Cr 1.78Cr 1.61Cr 3.04Cr 206.68Cr 3.07Cr 21Cr 8.35Cr 105.02Cr 8.01Cr 7.84Cr 337.76Cr | 137.03Cr 2.62Cr 2.34Cr 2.18Cr 1.98Cr 3.72Cr 253.27Cr 3.76Cr 26Cr 10Cr 128.7Cr 9.82Cr 9.61Cr 413.91Cr |
| Net income | 23Cr 43.49L 38.83L 36.23L 32.91L 61.92L 42Cr 62.53L 4.35Cr 1.7Cr 21Cr 1.63Cr 1.6Cr 69Cr | 26Cr 50.52L 45.11L 42.09L 38.23L 71.94L 49Cr 72.64L 5.05Cr 1.98Cr 25Cr 1.9Cr 1.86Cr 80Cr |
| Net Debt | 43Cr 82.61L 73.77L 68.82L 62.52L 1.18Cr 80Cr 1.19Cr 8.26Cr 3.23Cr 41Cr 3.1Cr 3.03Cr 130.76Cr | 44Cr 84.07L 75.08L 70.04L 63.62L 1.2Cr 81Cr 1.21Cr 8.41Cr 3.29Cr 41Cr 3.16Cr 3.09Cr 133.07Cr |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
